Investor · Cambridge, MA

Gino M. Santini

Open Gino in the network graph →

Filings

18

SEC Form D

Connections

26

co-filers

Capital

$59.6M

across filings

Active

Feb 2019

to Jul 2025

Most-connected co-filers (26)

Robert M. Armstrong, Ph.D · Cambridge, MA6 shared Peter B. Finn · Boston, MA5 shared David Pfeffer · New York, NY4 shared Damia Tormo · Cambridge, MA4 shared Javier Garcia · Cambridge, MA4 shared John Mcdonough · New York, NY3 shared Two Sigma Investments, LLC · NEW YORK, NY2 shared Matthew W. Clary · CHICAGO, IL2 shared Antonio Sierra · Washington, Washington, D.C.2 shared Gregory W. Link · GRAND CAYMAN, Cayman Islands2 shared Two Sigma Principals, LLC · New York, NY2 shared Afsaneh Beschloss · Washington, Washington, D.C.2 shared Zhenfu Li · Beijing, Israel2 shared Ad Oliver · Diemen, P72 shared Kathryn A. Hall · San Francisco, CA2 shared Karim Fadel · Cambridge, MA2 shared Ralph N. Woodford · Grand Cayman, Cayman Islands2 shared Bruno Sollazzo · George Town, Grand Cayman, Cayman Islands2 shared Ileana G. Bolcato · George Town, Grand Cayman, Cayman Islands2 shared Francesco G. Sisci · George Town, Grand Cayman, Cayman Islands2 shared Jan W. De Vries, Ph.D · Cambridge, MA1 shared Paul Hsu · Beijing, Israel1 shared Henri Termeer · Cambridge, MA1 shared Arthur Steinmetz · New York, NY1 shared

Recent filings (18)

STEELPATH MLP PARTNERS, LPMar 2018 · 4 co-filers STEELPATH MLP PARTNERS, LPMar 2017 · 4 co-filers STEELPATH MLP PARTNERS, LPApr 2016 · 4 co-filers GL China Opportunities Fund II L.P.Dec 2015 · 12 co-filers$600.0M Artax Biopharma, Inc.Oct 2015 · 16 co-filers$10.0M STEELPATH MLP PARTNERS, LPDec 2014 · 4 co-filers GL China Opportunities Fund II L.P.Dec 2014 · 12 co-filers$600.0M Artax Biopharma, Inc.Nov 2014 · 13 co-filers$2.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Gino in the interactive graph →